Hemothorax after fetal pleural effusion-thoracoamniotic shunting procedure due to transient myeloproliferative disorder-Reference-Cited by-同舟云学术

Hemothorax after fetal pleural effusion-thoracoamniotic shunting procedure due to transient myeloproliferative disorder

Published:2022-01-01 Issue:1 Volume:11 Page:
ISSN:2192-8959
Container-title:Case Reports in Perinatal Medicine
language:en
Short-container-title:

Author:

Iwahata Yuriko¹,Iwahata Hideyuki¹,Hasegawa Junichi¹^ORCID,Homma Chika¹,Nishimura Yoko¹,Kondo Haruhiro¹,Suzuki Nao¹

Affiliation:

1. Department Obstetrics and Gynecology , St. Marianna University School of Medicine , Kawasaki , Japan

Abstract

Abstract Objectives To present a case of fetal hemothorax after two times of thoracoamniotic shunting (TAS) performed to pleural effusion with hydrops fetalis, resulting in non-reassuring fetal status due to hemothorax. Case presentation This is a case of bilateral pleural effusion with hydrops fetalis and polyhydramnios at 32 weeks gestation, in which unilateral fetal TAS was performed twice, resulting in non-reassuring fetal status due to hemothorax. After delivery, the infant was diagnosed with trisomy 21 and transient myeloproliferative disorder (TMD) with disseminated intravascular coagulation and congenital systemic lymphangiopathy. Conclusions In conclusion, since TAM case do not always show hemothrax, TAM is not inhibited but technical carefulness should be necessary.

Publisher

Walter de Gruyter GmbH

Subject

Obstetrics and Gynecology,Embryology,Pediatrics, Perinatology and Child Health

Link

https://www.degruyter.com/document/doi/10.1515/crpm-2021-0032/pdf

Reference7 articles.

1. Yinon, Y, Kelly, E, Ryan, G. Fetal pleural effusions. Best Pract Res Clin Obstet Gynaecol 2008;22:77–96. https://doi.org/10.1016/j.bpobgyn.2007.09.004.

2. Yinon, Y, Grisaru-Granovsky, S, Chaddha, V, Windrim, R, Seaward, PGR, Kelly, EN, et al.. Perinatal outcome following fetal chest shunt insertion for pleural effusion. Ultrasound Obstet Gynecol 2010;36:58–64. https://doi.org/10.1002/uog.7507.

3. Hartung, J, Chaoui, R, Wauer, R, Bollmann, R. Fetal hepatosplenomegaly: an isolated sonographic sign of trisomy 21 in a case of myeloproliferative disorder. Ultrasound Obstet Gynecol 1998;11:453–5. https://doi.org/10.1046/j.1469-0705.1998.11060453.x.

4. Ogawa, M, Hosoya, N, Sato, A, Tanaka, T. Is the degree of fetal hepatosplenomegaly with transient abnormal myelopoiesis closely related to the postnatal severity of hematological abnormalities in down syndrome? Ultrasound Obstet Gynecol 2004;24:83–5. https://doi.org/10.1002/uog.1054.

5. Smrcek, JM, Baschat, AA, Germer, U, Gloeckner-Hofmann, K, Gembruch, U. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21. Ultrasound Obstet Gynecol 2001;17:403–9. https://doi.org/10.1046/j.1469-0705.2001.00384.x.